Enovis (ENOV) Other Non-Current Liabilities (2010 - 2026)
Enovis' (ENOV) quarterly Other Non-Current Liabilities came in at $368.6 million in Q3 2026, down 18.18% year-over-year from $450.6 million in Q3 2025, and down 6.39% quarter-over-quarter from $393.8 million in Q2 2026.
Analysis
Enovis (ENOV) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Enovis (ENOV) has reported Other Non-Current Liabilities for 17 consecutive years, with $368.6 million the latest figure, recorded in Q3 2026.
- On a quarterly basis, Other Non-Current Liabilities fell 18.18% year-over-year to $368.6 million in Q3 2026; TTM through Jul 2026 was $368.6 million, a 18.18% decrease from a year earlier, with the FY2025 full-year figure at $424.6 million, up 61.12% from the prior year.
- Other Non-Current Liabilities was $368.6 million for Q3 2026 at Enovis, down from $393.8 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $601.0 million in Q2 2022 and troughed at $130.7 million in Q3 2022.
- A 5-year average of $293.7 million and a median of $259.4 million in 2024 frame the typical range for Other Non-Current Liabilities.
- Across the five-year window, Other Non-Current Liabilities sank 79.17% in 2022 and jumped 96.44% in 2024, its largest moves.
- Over 5 years, Other Non-Current Liabilities stood at $167.0 million in 2022, then advanced by 22.27% to $204.2 million in 2023, then gained by 29.06% to $263.5 million in 2024, then soared by 61.12% to $424.6 million in 2025, then declined by 13.18% to $368.6 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $368.6 million (Q3 2026), $393.8 million (Q2 2026), and $424.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.92 Bn | 176.31 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.64 Bn | 122.42 Bn | 1.96 Bn |
| 3 | Medtronic | 117.92 Bn | 109.10 Bn | 6.34 Bn |
| 4 | Stryker | 105.39 Bn | 101.91 Bn | 4.50 Bn |
| 5 | Boston Scientific | 64.88 Bn | 64.34 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.92 Bn | 45.66 Bn | 1.35 Bn |
| 7 | Alcon | 33.24 Bn | 31.79 Bn | 1.68 Bn |
| 8 | Dexcom | 32.12 Bn | 30.18 Bn | 830.00 Mn |
| 9 | Steris | 20.83 Bn | 20.35 Bn | 684.20 Mn |
| 10 | Enovis | 1.08 Bn | 1.06 Bn | 359.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 368.63 Mn |
| Apr 3, 2026 | 393.81 Mn |
| Dec 31, 2025 | 424.57 Mn |
| Oct 3, 2025 | 437.01 Mn |
| Jul 4, 2025 | 450.56 Mn |
| Apr 4, 2025 | 360.70 Mn |
| Dec 31, 2024 | 263.52 Mn |
| Sep 27, 2024 | 313.76 Mn |
| Jun 28, 2024 | 255.20 Mn |
| Mar 29, 2024 | 249.05 Mn |
| Dec 31, 2023 | 204.18 Mn |
| Sep 29, 2023 | 159.73 Mn |
| Jun 30, 2023 | 191.55 Mn |
| Mar 31, 2023 | 170.53 Mn |
| Dec 31, 2022 | 166.99 Mn |
| Sep 30, 2022 | 130.67 Mn |
| Jul 1, 2022 | 144.24 Mn |
| Apr 1, 2022 | 601.02 Mn |
| Dec 31, 2021 | 122.16 Mn |
| Oct 1, 2021 | 627.37 Mn |